Decreased serum bilirubin is associated with silent cerebral infarction

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 4, 2014, Pages 946-951

  Li, Rui Yan ^a   Cao, Zhi Gang ^a   Zhang, Ji Rong ^a   Li, Ying ^a   Wang, Rui Tao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

atherosclerosis; bilirubin; cerebral infarction

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; BRAIN INFARCTION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PULSE WAVE; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ATHEROSCLEROSIS; BILIRUBIN; CEREBRAL INFARCTION;

ADULT; AGED; ANKLE BRACHIAL INDEX; ASYMPTOMATIC DISEASES; BILIRUBIN; BIOLOGICAL MARKERS; CEREBRAL INFARCTION; CHI-SQUARE DISTRIBUTION; CHINA; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; PULSE WAVE ANALYSIS; RISK FACTORS;

EID: 84897045542     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.303003     Document Type: Article

References (43)

1. Miwa K, Hoshi T, Hougaku H, Tanaka M, Furukado S, Abe Y, Okazaki S, Sakaguchi M, Sakoda S, Kitagawa K. Silent cerebral infarction is associated with incident stroke and TIA independent of carotid intima-media thickness. Intern Med. 2010;49:817-822.
2. Naganuma T, Uchida J, Tsuchida K, Takemoto Y, Tatsumi S, Sugimura K, Nakatani T. Silent cerebral infarction predicts vascular events in hemodi-Alysis patients. Kidney Int. 2005;67:2434-2439.
3. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.
4. Franchini M, Targher G, Lippi G. Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons? Adv Clin Chem. 2010;50:47-63.
5. Erdogan D, Gullu H, Yildirim E, Tok D, Kirbas I, Ciftci O, Baycan ST, Muderrisoglu H. Low serum bilirubin levels are independently and inversely related to impaired fow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis. 2006;184:431-437.
6. Kimm H, Yun JE, Jo J, Jee SH. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke. 2009;40:3422-3427.
7. Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol. 2008;28:166-172.
8. Vítek L, Jirsa M, Brodanová M, Kalab M, Marecek Z, Danzig V, Novotný L, Kotal P. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis. 2002;160:449-456.
9. Novotný L, Vítek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-Analysis of published studies. Exp Biol Med (Maywood). 2003;228:568-571.
10. Knottnerus IL, Ten Cate H, Lodder J, Kessels F, van Oostenbrugge RJ. Endothelial dysfunction in lacunar stroke: a systematic review. Cerebrovasc Dis. 2009;27:519-526.
11. Molvarec A, Rigó J Jr, Lázár L, Balogh K, Makó V, Cervenak L, Mézes M, Prohászka Z. Increased serum heat-shock protein 70 levels refect systemic infammation, oxidative stress and hepatocellular injury in pre-eclampsia. Cell Stress Chaperones. 2009;14:151-159.
12. Bulmer AC, Blanchfeld JT, Toth I, Fassett RG, Coombes JS. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis. 2008;199:390-396.
13. Vítek L, Zelenka J, Zadinová M, Malina J. The impact of intestinal micro-fora on serum bilirubin levels. J Hepatol. 2005;42:238-243.
14. Bennett BJ, de Aguiar Vallim TQ, Wang Z, Shih DM, Meng Y, Gregory J, Allayee H, Lee R, Graham M, Crooke R, Edwards PA, Hazen SL, Lusis AJ. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013;17:49-60.
15. Karlsson FH, Fåk F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, Bäckhed F, Nielsen J. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun. 2012;3:1245.
16. Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576-585.
17. Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, Breteler MM. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol. 2002;51:285-289.
18. Cho HC. The relationship among homocysteine, bilirubin, and diabetic retinopathy. Diabetes Metab J. 2011;35:595-601.
19. Basiglio CL, Arriaga SM, Pelusa F, Almará AM, Kapitulnik J, Mottino AD. Complement activation and disease: protective effects of hyperbiliru-binaemia. Clin Sci (Lond). 2010;118:99-113.
20. Kinderlerer AR, Pombo Gregoire I, Hamdulay SS, Ali F, Steinberg R, Silva G, Ali N, Wang B, Haskard DO, Soares MP, Mason JC. Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-Accelerating factor: a role for increased bilirubin and ferritin. Blood. 2009;113:1598-1607.
21. Satoh H, Kishi R, Tsutsui H. Metabolic syndrome is a signifcant and independent risk factor for increased arterial stiffness in Japanese subjects. Hypertens Res. 2009;32:1067-1071.
22. Tomiyama H, Tanaka H, Hashimoto H, Matsumoto C, Odaira M, Yamada J, Yoshida M, Shiina K, Nagata M, Yamashina A. Arterial stiffness and declines in individuals with normal renal function/early chronic kidney disease. Atherosclerosis. 2010;212:345-350.
23. Turin TC, Kita Y, Rumana N, Takashima N, Kadota A, Matsui K, Sugihara H, Morita Y, Nakamura Y, Miura K, Ueshima H. Brachial-Ankle pulse wave velocity predicts all-cause mortality in the general population: fndings from the Takashima study, Japan. Hypertens Res. 2010;33:922-925.
24. Xu L, Jiang CQ, Lam TH, Yue XJ, Cheng KK, Liu B, Jin YL, Zhang WS, Thomas GN. Brachial-Ankle pulse wave velocity and cardiovascular risk factors in the non-diabetic and newly diagnosed diabetic Chinese: Guangzhou Biobank Cohort Study-CVD. Diabetes Metab Res Rev. 2010;26:133-139.
25. Anan F, Shimomura T, Kaku T, Kaneda K, Imagawa M, Tsukagawa H, Masaki T, Nawata T, Yonemochi H, Eshima N, Saikawa T, Yoshimatsu H. High-sensitivity C-reactive protein level is a signifcant risk factor for silent cerebral infarction in patients on hemodialysis. Metabolism. 2008;57:66-70.
26. Satizabal CL, Zhu YC, Mazoyer B, Dufouil C, Tzourio C. Circulating IL-6 and CRP are associated with MRI fndings in the elderly: the 3C-Dijon Study. Neurology. 2012;78:720-727.
27. Cheriyath P, Gorrepati VS, Peters I, Nookala V, Murphy ME, Srouji N, Fischman D. High total bilirubin as a protective factor for diabetes mel-litus: an analysis of NHANES data from 1999-2006. J Clin Med Res. 2010;2:201-206.
28. Oda E, Kawai R. A possible cross-sectional association of serum total bili-rubin with coronary heart disease and stroke in a Japanese health screening population. Heart Vessels. 2012;27:29-36.
29. Asumi M, Yamaguchi T, Saito K, Kodama S, Miyazawa H, Matsui H, Suzuki E, Fukuda H, Sone H. Are serum cholesterol levels associated with silent brain infarcts? The Seiryo Clinic Study. Atherosclerosis. 2010;210:674-677.
30. Oncel C, Demir S, Güler S, Cenikli U, Tabak E, Kiroglu Y. Association between cholesterols, homocysteine and silent brain infarcts. Intern Med J. 2009;39:150-155.
31. Kato T, Inoue T, Yamagishi S, Morooka T, Okimoto T, Node K. Low-density lipoprotein subfractions and the prevalence of silent lacu-nar infarction in subjects with essential hypertension. Hypertens Res. 2006;29:303-307.
32. Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH. Bilirubin and glutathione have complementary antioxidant and cytopro-tective roles. Proc Natl Acad Sci USA. 2009;106:5171-5176.
33. Howard G, Wagenknecht LE, Cai J, Cooper L, Kraut MA, Toole JF. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke. 1998;29:913-917.
34. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke. 1997;28:1932-1939.
35. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2002;33:21-25.
36. López M, Dorado P, Ortega A, Peñas-Lledó E, Monroy N, Silva-Zolezzi I, Cobaleda J, Gallego-Aguilera A, Alonso ME, Llerena A. Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations. Mol Biol Rep. 2013;40:3187-3192.
37. Carmel R, Wong ET, Weiner JM, Johnson CS. Racial differences in serum total bilirubin levels in health and in disease (pernicious anemia). JAMA. 1985;253:3416-3418.
38. Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucurono- syltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat. 2000;16:297-306.
39. Hamden K, Jaouadi B, Carreau S, Aouidet A, Elfeki A. Therapeutic effects of soy isofavones on α-Amylase activity, insulin defciency, liver-kidney function and metabolic disorders in diabetic rats. Nat Prod Res. 2011;25:244-255.
40. Zhou J, Tracy TS, Remmel RP. Correlation between bilirubin gluc-uronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors. Drug Metab Dispos. 2011;39:322-329.
41. Smiderle L, Galvão AC, Fontana C, Wender MC, Agnes G, Giovenardi M, Hutz MH, Almeida S. Evaluation of UGT1A1 and SULT1A1 polymorphisms with lipid levels in women with different hormonal status. Gynecol Endocrinol. 2011;27:20-26.
42. Hwang HJ, Kim SH. Inverse relationship between fasting direct bili-rubin and metabolic syndrome in Korean adults. Clin Chim Acta. 2010;411:1496-1501.
43. Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem. 2010;56:1535-1543.